BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 19583517)

  • 1. Tuberculosis into the 2010s: is the glass half full?
    Ralph AP; Anstey NM; Kelly PM
    Clin Infect Dis; 2009 Aug; 49(4):574-83. PubMed ID: 19583517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis, a re-emergent disease.
    Valadas E; Antunes F
    Eur J Radiol; 2005 Aug; 55(2):154-7. PubMed ID: 15905058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Styblo model 20 years later: what holds true?
    Arnadottir T
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):672-90. PubMed ID: 19460242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New and improved tuberculosis diagnostics: evidence, policy, practice, and impact.
    Pai M; Minion J; Steingart K; Ramsay A
    Curr Opin Pulm Med; 2010 May; 16(3):271-84. PubMed ID: 20224410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Working towards TB elimination the WHO Regional Strategic Plan (2006-2015).
    Nair N; Cooreman E
    J Commun Dis; 2006 Mar; 38(3):185-90. PubMed ID: 17373351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stopping tuberculosis in the 21st century: goals and strategies.
    Onozaki I; Raviglione M
    Respirology; 2010 Jan; 15(1):32-43. PubMed ID: 20199633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensively drug-resistant tuberculosis: are we learning from history or repeating it?
    Dukes Hamilton C; Sterling TR; Blumberg HM; Leonard M; McAuley J; Schlossberg D; Stout J; Huitt G
    Clin Infect Dis; 2007 Aug; 45(3):338-42. PubMed ID: 17599311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings.
    Scano F; Vitoria M; Burman W; Harries AD; Gilks CF; Havlir D
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1370-5. PubMed ID: 19017444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.
    Harries AD; Hargreaves NJ; Chimzizi R; Salaniponi FM
    Bull World Health Organ; 2002; 80(6):464-9. PubMed ID: 12132003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Global TB Drug Facility: innovative global procurement.
    Kumaresan J; Smith I; Arnold V; Evans P
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):130-8. PubMed ID: 14974756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global epidemiology of tuberculosis: prospects for control.
    Lönnroth K; Raviglione M
    Semin Respir Crit Care Med; 2008 Oct; 29(5):481-91. PubMed ID: 18810682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
    Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
    J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of multidrug-resistant tuberculosis: Update 2007.
    Yew WW; Leung CC
    Respirology; 2008 Jan; 13(1):21-46. PubMed ID: 18197909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A research agenda to promote the management of childhood tuberculosis within national tuberculosis programmes.
    Donald PR; Maher D; Qazi S
    Int J Tuberc Lung Dis; 2007 Apr; 11(4):370-80. PubMed ID: 17394681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From HIV to tuberculosis and back again: a tale of activism in 2 pandemics.
    Harrington M
    Clin Infect Dis; 2010 May; 50 Suppl 3():S260-6. PubMed ID: 20397957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global tuberculosis trends: a reflection of changes in tuberculosis control or in population health?
    Oxlade O; Schwartzman K; Behr MA; Benedetti A; Pai M; Heymann J; Menzies D
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1238-46. PubMed ID: 19793428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward an optimized therapy for tuberculosis? Drugs in clinical trials and in preclinical development.
    Ma Z; Lienhardt C
    Clin Chest Med; 2009 Dec; 30(4):755-68, ix. PubMed ID: 19925965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How research can help control tuberculosis.
    Chaisson RE; Harrington M
    Int J Tuberc Lung Dis; 2009 May; 13(5):558-68. PubMed ID: 19383187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How research can help control tuberculosis.
    Chaisson RE; Harrington M
    World Hosp Health Serv; 2010; 46(1):33-40. PubMed ID: 20614683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.
    Mitrzyk BM
    Pharmacotherapy; 2008 Oct; 28(10):1243-54. PubMed ID: 18823220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.